Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.

Norbert M Wikonkal; Eva Remenyik; Dejan Knezevic; Wengeng Zhang; Ming Liu; Hongyu Zhao; T R Berton; David G Johnson; Douglas E Brash

doi:10.1038/ncb1001

Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.

Identifier:nobleid.org/w1/20260515/90CEF2C1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/90CEF2C1.svg?ark=w1%2F20260515%2F90CEF2C1)](https://nobleid.org/work/w1/20260515/90CEF2C1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.

Identifier:nobleid.org/w1/20260515/90CEF2C1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/90CEF2C1.svg?ark=w1%2F20260515%2F90CEF2C1)](https://nobleid.org/work/w1/20260515/90CEF2C1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work